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Introduction
Optimizing	growth	rate	is	an	important	contributor	to	overall	profitability	for	stocker	
cattle	grazing	native	Flint	Hills	pasture.	Disease	challenges	from	pinkeye	and	foot	rot	
have	traditionally	been	problems	that	compromise	health	and	productivity	of	stocker	
cattle	in	this	grazing	region.	Use	of	medicinal	feed	additives	as	a	part	of	a	supplementa-
tion	program	may	prevent	health	problems	and	improve	overall	productivity	during	a	
spring/summer	grazing	season.
Experimental Procedures
A	90-day	grazing	study	was	conducted	at	the	Kansas	State	University	Beef	Stocker	
Unit	starting	in	May	2008	to	determine	the	efficacy	of	supplementation	programs	that	
provide	medicinal	feed	additives	for	managing	growth	and	health	of	stocker	calves	graz-
ing	native	grass	pastures	in	the	Flint	Hills	region	of	Kansas.	All	steers	used	in	this	study	
(306	head)	were	previously	involved	in	a	receiving	study	that	focused	on	arrival	mass	
medication	programs.	Off-test	weights	collected	at	the	conclusion	of	the	receiving	study	
were	used	to	randomly	assign	each	animal	to	grazing	treatments.	Steers	were	assigned	
to	two	grazing	treatments	with	six	pasture	replicates	per	treatment.	All	paddocks	were	
stocked	at	250	lb	beef	per	acre.	
On	April	30,	all	calves	were	tagged,	dewormed	with	Eprinex	(Merial,	Duluth,	GA),	
and	sorted	to	their	preassigned	paddock	groups.	The	grazing	season	began	on	May	1	
and	ended	on	July	30.	Treatment	1	(herein	referred	to	as	BA)	consisted	of	a	free-choice	
mineral	formulated	with	Bovatec	and	Aureomycin	(Alpharma	Inc.,	Ridgefield	Park,	NJ;	
200	and	350	mg/head	per	daily,	respectively).	Treatment	2	(herein	referred	to	as	RU)	
consisted	of	a	free-choice	mineral	formulated	with	micronutrient	content	equal		
to	BA	but	instead	containing	Rumensin	(Elanco	Animal	Health,	Indianapolis,	IN;		
200	mg/head	daily).	Both	treatments	were	provided	throughout	the	duration	of	the	
grazing	study.	Intake	level	for	both	self-fed	supplements	was	targeted	at	0.25	lb/head	
per	day	to	achieve	intended	drug	levels.	
Mineral	in	the	feeder	of	each	paddock	was	checked	weekly	for	manure,	water,	or	other	
foreign	matter	that	could	interfere	with	normal	supplement	consumption.	Bull	Master	
feeders	(Mann	Enterprises,	Inc.,	Waterville,	KS)	were	used	for	mineral	delivery	in	all	
paddocks.	When	inclement	weather	was	forecasted,	rubber	flap	covers	on	all	feeders	
were	closed	to	minimize	moisture	contamination.	All	flaps	were	reopened	immedi-
ately	after	the	threatening	storm	event.	Each	mineral	feeder	was	weighed	weekly,	and	
the	readings	were	recorded.	The	collected	numbers	were	used	to	calculate	the	previ-
ous	week’s	mineral	intake.	If	mineral	intake	was	beyond	target,	the	feeder	was	moved	
further	away	from	the	primary	water	source.	If	this	initial	action	did	not	effectively	
reduce	mineral	intake,	salt	blocks	were	placed	next	to	feeders.	
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All	calves	were	inspected	daily	for	symptoms	of	sickness	or	lameness.	Cattle	diagnosed	
with	foot	rot	and	pinkeye	received	the	label	dosage	of	Bio-Mycin	200	(Boehringer-
Ingelheim,	Ridgefield,	CT).	First-treatment	bovine	respiratory	disease	diagnosed	calves	
received	the	label	dosage	of	Baytril	100	(Bayer	Animal	Health,	Shawnee	Mission,	KS),	
and	second-treatment	bovine	respiratory	disease	diagnosed	calves	received	the	label	
dosage	of	Nuflor	(Intervet/Schering-Plough	Animal	Health,	The	Netherlands).	Upon	
conclusion	of	the	study,	all	steers	were	placed	in	drylot	for	5	days	and	fed	at	a	constant	
level	of	2.5%/head	per	day	(dry	matter	basis)	to	equalize	gut	fill.	The	diet	consisted	of	
cracked	corn,	wet	corn	gluten	feed,	prairie	hay,	and	alfalfa	hay.	At	the	end	of	the	5-day	
post-grass	period,	all	steers	were	individually	weighed.
Performance	and	health	data	were	analyzed	by	using	the	mixed	model	procedure	of	
SAS	(SAS	Institute	Inc.,	Cary,	NC).	Data	were	arranged	in	a	randomized	complete	
block	design;	pasture	served	as	the	experimental	unit	for	growth	and	health	outcomes	
as	affected	by	treatment.	In	the	model,	fixed	effects	were	treatment	and	pasture,	and	
random	effects	were	pasture	×	treatment,	pasture,	and	animal	ID.	Percentages	of	foot	
rot	morbidity	and	mortality	were	tested	by	using	the	Chi-Square	test,	and	significance	
was	declared	at	P<0.05.	
Results and Discussion
Table	1	shows	average	intake	of	the	supplemental	mineral	treatments	during	the	
90-day	grazing	study.	Although	intake	of	the	BA	mineral	slightly	exceeded	the	targeted	
level,	intake	of	the	RU	treatment	was	40%	lower	than	desired.	Actual	concentrations	
of	Bovatec	and	Aureomycin	were	well	within	the	desired	dosage	range,	especially	
compared	with	the	very	low	consumption	of	Rumensin	that	was	realized	as	a	conse-
quence	of	poor	mineral	intake.
Figure	1	graphically	depicts	weekly	mineral	consumption	throughout	the	entire	trial	
and	reveals	a	significant	week	×	mineral	treatment	effect	(P<0.0001).	At	the	onset	
of	the	trial,	BA	mineral	consumption	exceeded	desired	intake	targets.	Intake	of	this	
mineral	was	abruptly	reduced	by	week	6	and	gradually	increased	to	the	desired	intake	
target	for	the	remainder	of	the	study.	In	contrast,	RU	mineral	intake	never	reached	
desired	target	levels.	
Although	RU	mineral	consumption	was	significantly	less	(P<0.01)	than	BA	mineral	
consumption	throughout	the	entire	grazing	season,	there	were	no	significant	differences	
(P=0.45)	in	daily	gain	between	treatments	(Table	2).
There	were	no	significant	differences	between	treatments	for	pink	eye	and	respira-
tory	disease,	(Table	3),	but	incidence	of	foot	rot	was	reduced	in	cattle	consuming	BA	
mineral	(P<0.09).
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Table 1. Average intake of mineral mixes used in experiment
Treatment
Item
Aureomycin/
Bovatec Rumensin SEM
No.	of	stockers 155 148
No.	of	pasture	groups 6 6
Mineral	intake,	oz/head	per	day 4.22 2.39 0.01
Medication	intake,	mg/head	per	day	–	calculated	(actual)
Aureomycin 369	(325)
Lasalocid 211	(186)
Rumensin 120	(105)
Table 2. Effect of mineral medication treatments on stocker performance
Treatment
Item
Aureomycin/
Bovatec Rumensin SEM P-value
On-test	stocker	weight,	lb 583 582 4.1 0.84
Off-test	stocker	weight,	lb 739 743 5.3 0.61
90-d	daily	gain 1.732 1.796 0.06 0.4495
Table 3. Effect of mineral medication treatments on incidence of stocker health prob-
lems
Treatment
Item
Aureomycin/
Bovatec Rumensin SEM P-value
No.	of	stockers 155 148
Percentage	of	cattle	treated	for	illness
Foot	rot 4.68 16.88 4.65 0.0930
Pink	eye 0.63 0.0 0.45 0.3409
Respiratory	diseases 0.67 0.62 0.64 0.9572
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Figure 1. Weekly consumption of medicated mineral mixtures.  
